TRIANA Biomedicines
Series BTRIANA Biomedicines is a privately held company based in United States, founded in 2021. The latest disclosed round is Series B ($120m), dated Nov 26, 2025. Institutional investors on record include Bessemer Venture Partners, Lightspeed Venture Partners. Latest valuation on file is 32,1M (Sep 12, 2024).
United States · EST 2021
What is TRIANA Biomedicines?
TRIANA Biomedicines is a privately held company based in United States, founded in 2021. The latest disclosed round is Series B ($120m), dated Nov 26, 2025. Institutional investors on record include Bessemer Venture Partners, Lightspeed Venture Partners. Latest valuation on file is 32,1M (Sep 12, 2024). Developer of precision medicine for the treatment of cancer. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed TRIANA Biomedicines?
Who invested in TRIANA Biomedicines?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Bessemer Venture Partners | Series B | $120m | Nov 26, 2025 |
| Lightspeed Venture Partners | Series B | $120m | Nov 26, 2025 |
What do founders ask about TRIANA Biomedicines?
What is TRIANA Biomedicines?
TRIANA Biomedicines is a privately held company based in United States, founded in 2021. The latest disclosed round is Series B ($120m), dated Nov 26, 2025. Institutional investors on record include Bessemer Venture Partners, Lightspeed Venture Partners. Latest valuation on file is 32,1M (Sep 12, 2024). Developer of precision medicine for the treatment of cancer. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was TRIANA Biomedicines's last funding round?
TRIANA Biomedicines's latest disclosed round is Series B at $120m (Nov 26, 2025).
Who invested in TRIANA Biomedicines?
TRIANA Biomedicines has 2 institutional investors on this page, including Bessemer Venture Partners, Lightspeed Venture Partners.
How does CrackTheDeck cover TRIANA Biomedicines?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the TRIANA Biomedicines card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.